Two recent disappointing clinical trials of highly-anticipated weight-loss drugs have made it clear that it is too early to ...

It appears an unintended side effect of the drug has now struck some of Britain's known suitmakers, who are fed up with ...

The market for GLP-1 drugs is projected to exceed $200 billion in annual sales by 2031, according to Morningstar Equity Research. Current market leaders include Novo Nordisk NVO and Eli Lilly LLY with ...

Karen Huger revealed whether she's using Ozempic, explaining she's using a medication for a reason other than weight loss. Learn more.

A new study found people with type 2 diabetes who used drugs like Ozempic had a reduced risk of 42 health conditions or ...

The findings, based on an analysis of records from 2.5 million VA patients, support much of what scientists already suspected ...

The benefits of taking GLP-1 agonists seem to outweigh the risks, at least when taken for approved uses, according to an ...

The study included nearly 2 million patients, making it the largest ever conducted on this group of glucagon-like peptide-1 ...

Over 2 million people were included in new research to test these drugs against 175 different health outcomes.

Ozempic has become a hot topic, but is it really safe? Discover the benefits, risks, and why so many people are turning to it for weight loss and diabetes management.

Novo Nordisk has faced a massive selloff in recent months amid disappointing drug trials and U.S. pressure to cut its prices.

WAYNESBORO, Va. (WHSV) - Bobby Miller pleaded guilty to one count of drug distribution between Roanoke and Waynesboro after Waynesboro police tracked his phone during a run.